This page shows the latest drug treatment news and features for those working in and with pharma, biotech and healthcare.
The antibody drug treatment has thus far only been authorised for emergency use by the FDA to treat COVID-19 in specific emergency cases in non-hospital settings. ... Bebtelovimab has not been approved, but has been given an Emergency Use Authorisation
If finalised, the proposed rule would require drug companies to include an additional condition for nonprescription use when submitting a new application to bring a nonprescription drug treatment to market. ... Under the proposed rule, when the FDA finds
Zeposia was initially approved by the US Food and Drug Administration (FDA) for the treatment of relapsing forms of MS in March 2020, while the European Commission also authorised the drug ... for the treatment of adult patients with relapsing remitting
The deal, worth up to $480m, involves the first novel antifungal treatment developed in the last 20 years. ... It also covers azole-resistant strains, coccidioidomycosis and scedosporiosis (including lomentosporiosis). The treatment has already been
There are no approved treatment options available for acute agitation related to dementia. ... BXCL501 was granted an earlier Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for the acute treatment of agitation in dementia,
Veklury is currently the only COVID-19 treatment approved for this age group. ... For hospitalised patients who do not require invasive mechanical ventilation and/or ECMO, a five-day treatment course is recommended.
More from news
Approximately 2 fully matching, plus 976 partially matching documents found.
treatment. The world- class Sidra Medicine hospital and the Qatar Biomedical Research Institute are using genomes to identify personalised lifestyle interventions to tackle obesity. ... of the right drug treatment for the individual.
In 2021 we can expect more clinical studies that produce meaningful data, more advanced research and an increase in drug approvals that offer truly innovative treatment options. ... We’re looking at digital advances that would improve access to
to find an effective drug treatment for patients and the journey of remdesivir that began a decade ago as part of Gilead’s emerging viruses programme. ... The World Health Organization (WHO) has not included Gilead’s antiviral treatment remdesivir in
treatment or breakthrough drug?
This influx of capital means there are already close to 200 start-ups using AI in drug discovery. ... Take, for example, the case of baricitinib, originally an Eli Lilly rheumatoid arthritis drug, now repurposed as a promising treatment for COVID-19.
More from intelligence
Approximately 0 fully matching, plus 50 partially matching documents found.
In his new role he will join Turku-based Faron's executive management team and oversee its drug development strategy, including its clinical programmes for Traumakine and Clevegen. ... Our lead drug candidate Traumakine, for the treatment of Acute
As chief medical officer at Canbex Dr Lledó will lead preparations for proof of concept trials for the company's lead candidate VSN16R, an oral drug intended for the treatment of ... As a practicing neurologist and experienced drug developer, I am very
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Drug trials are often competing with each other as pharmaceutical rivals race to be the first to develop a drug or treatment. ... treatment and one they would wish to be aware of so they have the chance to participate.
The current focus of Actigen's work is on the development of a drug for a potential breakthrough treatment for the life-limiting rare disease known as MPS II or Hunter ... There are 6, 000 rare diseases affecting approximately 300 million people worldwide
There is only a very small target market, meaning that the company developing the treatment would find it difficult to cover the development costs of a new drug, while also keeping ... In February this year, it was announced that the world’s most
The campaign shares their unique reasons for carrying naloxone, a drug that they now all carry. ... pharmacies and drug treatment centres, ensuring the lifesaving message reaches the people who need to see it.
When this starts earlier in the development process, it proves to be hugely beneficial in demonstrating the tangible value to the patient of the drug or treatment, the support structure surrounding ... Understanding the patient. Exactly how this
More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.